Statements (28)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:antibiotic
cephalosporin |
| gptkbp:ATCCode |
gptkb:J01DB04
|
| gptkbp:brand |
gptkb:Ancef
gptkb:Kefzol |
| gptkbp:CASNumber |
25953-19-9
|
| gptkbp:contraindication |
hypersensitivity to cephalosporins
|
| gptkbp:discoveredIn |
1960s
|
| gptkbp:eliminationHalfLife |
1.8 hours
|
| gptkbp:excretion |
renal
|
| gptkbp:hasMolecularFormula |
C14H14N8O4S3
|
| https://www.w3.org/2000/01/rdf-schema#label |
cefazolin
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:mechanismOfAction |
inhibits bacterial cell wall synthesis
|
| gptkbp:pregnancyCategory |
B (US)
|
| gptkbp:proteinBinding |
80%
|
| gptkbp:routeOfAdministration |
intramuscular
intravenous |
| gptkbp:sideEffect |
nausea
diarrhea rash allergic reactions |
| gptkbp:spectrumOfActivity |
gram-positive bacteria
some gram-negative bacteria |
| gptkbp:usedFor |
bacterial infections
|
| gptkbp:WHOModelListOfEssentialMedicines |
included
|
| gptkbp:bfsParent |
gptkb:MSSA
|
| gptkbp:bfsLayer |
6
|